These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 28367241)
1. MicroRNA-200a inhibits cell growth and metastasis by targeting Foxa2 in hepatocellular carcinoma. Chen SY; Ma DN; Chen QD; Zhang JJ; Tian YR; Wang ZC; Cai H; Lin Y; Sun HC J Cancer; 2017; 8(4):617-625. PubMed ID: 28367241 [No Abstract] [Full Text] [Related]
2. MiR-200a promotes epithelial-mesenchymal transition of endometrial cancer cells by negatively regulating FOXA2 expression. Shi W; Wang X; Ruan L; Fu J; Liu F; Qu J Pharmazie; 2017 Nov; 72(11):694-699. PubMed ID: 29442045 [TBL] [Abstract][Full Text] [Related]
3. miR-92a promotes hepatocellular carcinoma cells proliferation and invasion by FOXA2 targeting. Wang L; Wu J; Xie C Iran J Basic Med Sci; 2017 Jul; 20(7):783-790. PubMed ID: 28852443 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA-200a inhibits epithelial-mesenchymal transition in human hepatocellular carcinoma cell line. Zhong C; Li MY; Chen ZY; Cheng HK; Hu ML; Ruan YL; Guo RP Int J Clin Exp Pathol; 2015; 8(9):9922-31. PubMed ID: 26617701 [TBL] [Abstract][Full Text] [Related]
5. ERRATUM. Wang J; Song W; Shen W; Yang X; Sun W; Qu S; Shang R; Ma B; Pu M; Tao K; Dou K; Li H Oncol Res; 2019 Feb; 27(2):281-282. PubMed ID: 30696521 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA-138 targets SP1 to inhibit the proliferation, migration and invasion of hepatocellular carcinoma cells. Liu C; Zhu J; Liu F; Wang Y; Zhu M Oncol Lett; 2018 Jan; 15(1):1279-1286. PubMed ID: 29387246 [TBL] [Abstract][Full Text] [Related]
7. Identification a novel tumor-suppressive hsa-miR-599 regulates cells proliferation, migration and invasion by targeting oncogenic MYC in hepatocellular carcinoma. Tian J; Hu X; Gao W; Zhang J; Chen M; Zhang X; Ma J; Yuan H Am J Transl Res; 2016; 8(6):2575-84. PubMed ID: 27398141 [TBL] [Abstract][Full Text] [Related]
8. The histone deacetylase 4/SP1/microrna-200a regulatory network contributes to aberrant histone acetylation in hepatocellular carcinoma. Yuan JH; Yang F; Chen BF; Lu Z; Huo XS; Zhou WP; Wang F; Sun SH Hepatology; 2011 Dec; 54(6):2025-35. PubMed ID: 21837748 [TBL] [Abstract][Full Text] [Related]
9. MicroRNA-200a and microRNA-141 have a synergetic effect on the suppression of epithelial-mesenchymal transition in liver cancer by targeting STAT4. Chen S; Zhang J; Chen Q; Cheng J; Chen X; Mao Y; Chen W; Liu C; Wu H; Lv Y; Lin Y Oncol Lett; 2021 Feb; 21(2):137. PubMed ID: 33552256 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA-370 Regulates Cellepithelial-Mesenchymal Transition, Migration, Invasion, and Prognosis of Hepatocellular Carcinoma by Targeting GUCD1. He Y; He X Yonsei Med J; 2019 Mar; 60(3):267-276. PubMed ID: 30799589 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity. Xu L; Beckebaum S; Iacob S; Wu G; Kaiser GM; Radtke A; Liu C; Kabar I; Schmidt HH; Zhang X; Lu M; Cicinnati VR J Hepatol; 2014 Mar; 60(3):590-8. PubMed ID: 24211739 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-200a inhibits CD133/1+ ovarian cancer stem cells migration and invasion by targeting E-cadherin repressor ZEB2. Wu Q; Guo R; Lin M; Zhou B; Wang Y Gynecol Oncol; 2011 Jul; 122(1):149-54. PubMed ID: 21529905 [TBL] [Abstract][Full Text] [Related]
13. miR-200a-3p facilitates bladder cancer cell proliferation by targeting the Wan P; Chen Z; Huang M; Jiang H; Wu H; Zhong K; Ding G; Wang B Transl Androl Urol; 2021 Nov; 10(11):4262-4274. PubMed ID: 34984191 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA-188-5p suppresses tumor cell proliferation and metastasis by directly targeting FGF5 in hepatocellular carcinoma. Fang F; Chang RM; Yu L; Lei X; Xiao S; Yang H; Yang LY J Hepatol; 2015 Oct; 63(4):874-85. PubMed ID: 25998163 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA-493 suppresses cell proliferation and invasion by targeting ZFX in human hepatocellular carcinoma. Ding W; Tan H; Li X; Zhang Y; Fang F; Tian Y; Li J; Pan X Cancer Biomark; 2018; 22(3):427-434. PubMed ID: 29758928 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA-101 suppresses migration and invasion via targeting vascular endothelial growth factor-C in hepatocellular carcinoma cells. Liu Z; Wang J; Mao Y; Zou B; Fan X Oncol Lett; 2016 Jan; 11(1):433-438. PubMed ID: 26870229 [TBL] [Abstract][Full Text] [Related]
17. MiR-451a suppresses cell proliferation, metastasis and EMT via targeting YWHAZ in hepatocellular carcinoma. Wei GY; Hu M; Zhao L; Guo WS Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5158-5167. PubMed ID: 31298411 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-98-5p Inhibits Tumorigenesis of Hepatitis B Virus-Related Hepatocellular Carcinoma by Targeting NF-κB-Inducing Kinase. Fei X; Zhang P; Pan Y; Liu Y Yonsei Med J; 2020 Jun; 61(6):460-470. PubMed ID: 32469170 [TBL] [Abstract][Full Text] [Related]
19. miRNA-320a inhibits tumor proliferation and invasion by targeting c-Myc in human hepatocellular carcinoma. Xie F; Yuan Y; Xie L; Ran P; Xiang X; Huang Q; Qi G; Guo X; Xiao C; Zheng S Onco Targets Ther; 2017; 10():885-894. PubMed ID: 28243124 [TBL] [Abstract][Full Text] [Related]
20. Downregulation of miR-200a-3p induced by hepatitis B Virus X (HBx) Protein promotes cell proliferation and invasion in HBV-infection-associated hepatocarcinoma. Shi T; Hua Q; Ma Z; Lv Q Pathol Res Pract; 2017 Dec; 213(12):1464-1469. PubMed ID: 29103765 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]